Review



soluble recombinant galectin-9  (Galectin Therapeutics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Galectin Therapeutics soluble recombinant galectin-9
    Soluble Recombinant Galectin 9, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/soluble+recombinant+galectin-9/soluble+galectin+9/pm39503215-300-5-6
    Average 90 stars, based on 1 article reviews
    soluble recombinant galectin-9 - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: CD137 Protein Expression Pattern Determines the Functional Role of Galectin-9 in Colorectal Cancer.
    Article Snippet: In animal studies, administering soluble recombinant Galectin‐9 to mice with inflammatory disease models generally shows an inhibitory effect on disease activity, indicating its potential role in immune suppression [14].

    Recombinant:

    Article Title: Treg-mediated Suppression of Inflammation Induced by DR3 Signaling is Dependent on Galectin-9
    Article Snippet: Nevertheless, studies of soluble recombinant Galectin-9 injected into animals have shown it is highly inhibitory and may have clinical potential to block inflammation ( 30 ). .. Soluble recombinant Galectin-9 can suppress inflammatory disease in models of EAE, arthritis, and diabetes ( 12 , 20 , 31 – 33 ), and it has been suggested to do this by either promoting the accumulation and activity of Tregs ( 12 , 34 – 40 ) or leading to apoptosis or death in some effector T cells ( 36 , 41 – 43 ). .. A major question is what are the glycoprotein receptors that recombinant Galectin-9 engages to exert these actions.

    Article Title: Treg-mediated Suppression of Inflammation Induced by DR3 Signaling is Dependent on Galectin-9
    Article Snippet: Endogenously produced Galectin-9 is thought to act primarily as a cell surface associated protein or intracellularly, and circulating levels of soluble Galectin-9 are generally low unless an inflammatory response is occurring. .. Nevertheless, studies of soluble recombinant Galectin-9 injected into animals have shown it is highly inhibitory and may have clinical potential to block inflammation ( 30 ). .. Soluble recombinant Galectin-9 can suppress inflammatory disease in models of EAE, arthritis, and diabetes ( 12 , 20 , 31 – 33 ), and it has been suggested to do this by either promoting the accumulation and activity of Tregs ( 12 , 34 – 40 ) or leading to apoptosis or death in some effector T cells ( 36 , 41 – 43 ).

    Activity Assay:

    Article Title: Treg-mediated Suppression of Inflammation Induced by DR3 Signaling is Dependent on Galectin-9
    Article Snippet: Nevertheless, studies of soluble recombinant Galectin-9 injected into animals have shown it is highly inhibitory and may have clinical potential to block inflammation ( 30 ). .. Soluble recombinant Galectin-9 can suppress inflammatory disease in models of EAE, arthritis, and diabetes ( 12 , 20 , 31 – 33 ), and it has been suggested to do this by either promoting the accumulation and activity of Tregs ( 12 , 34 – 40 ) or leading to apoptosis or death in some effector T cells ( 36 , 41 – 43 ). .. A major question is what are the glycoprotein receptors that recombinant Galectin-9 engages to exert these actions.

    Injection:

    Article Title: Treg-mediated Suppression of Inflammation Induced by DR3 Signaling is Dependent on Galectin-9
    Article Snippet: Endogenously produced Galectin-9 is thought to act primarily as a cell surface associated protein or intracellularly, and circulating levels of soluble Galectin-9 are generally low unless an inflammatory response is occurring. .. Nevertheless, studies of soluble recombinant Galectin-9 injected into animals have shown it is highly inhibitory and may have clinical potential to block inflammation ( 30 ). .. Soluble recombinant Galectin-9 can suppress inflammatory disease in models of EAE, arthritis, and diabetes ( 12 , 20 , 31 – 33 ), and it has been suggested to do this by either promoting the accumulation and activity of Tregs ( 12 , 34 – 40 ) or leading to apoptosis or death in some effector T cells ( 36 , 41 – 43 ).

    Blocking Assay:

    Article Title: Treg-mediated Suppression of Inflammation Induced by DR3 Signaling is Dependent on Galectin-9
    Article Snippet: Endogenously produced Galectin-9 is thought to act primarily as a cell surface associated protein or intracellularly, and circulating levels of soluble Galectin-9 are generally low unless an inflammatory response is occurring. .. Nevertheless, studies of soluble recombinant Galectin-9 injected into animals have shown it is highly inhibitory and may have clinical potential to block inflammation ( 30 ). .. Soluble recombinant Galectin-9 can suppress inflammatory disease in models of EAE, arthritis, and diabetes ( 12 , 20 , 31 – 33 ), and it has been suggested to do this by either promoting the accumulation and activity of Tregs ( 12 , 34 – 40 ) or leading to apoptosis or death in some effector T cells ( 36 , 41 – 43 ).



    Similar Products

    soluble recombinant galectin-9  (Galectin Therapeutics)
    90
    Galectin Therapeutics soluble recombinant galectin-9
    Soluble Recombinant Galectin 9, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/soluble+recombinant+galectin-9/soluble+galectin+9/pm39503215-300-5-6
    Average 90 stars, based on 1 article reviews
    soluble recombinant galectin-9 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results